BR9503845A - Processo para a preparação de um composto e composto obtido - Google Patents

Processo para a preparação de um composto e composto obtido

Info

Publication number
BR9503845A
BR9503845A BR9503845A BR9503845A BR9503845A BR 9503845 A BR9503845 A BR 9503845A BR 9503845 A BR9503845 A BR 9503845A BR 9503845 A BR9503845 A BR 9503845A BR 9503845 A BR9503845 A BR 9503845A
Authority
BR
Brazil
Prior art keywords
compound
preparation
useful
obtained compound
benzodiazepines
Prior art date
Application number
BR9503845A
Other languages
English (en)
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Milton Josepf Zmijewski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9503845A publication Critical patent/BR9503845A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9503845A 1994-08-31 1995-08-30 Processo para a preparação de um composto e composto obtido BR9503845A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
BR9503845A true BR9503845A (pt) 1996-04-16

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9503845A BR9503845A (pt) 1994-08-31 1995-08-30 Processo para a preparação de um composto e composto obtido

Country Status (22)

Country Link
US (3) US5919954A (pt)
EP (1) EP0699677B1 (pt)
JP (1) JP3481019B2 (pt)
KR (1) KR100399518B1 (pt)
CN (1) CN1086705C (pt)
AT (1) ATE231867T1 (pt)
AU (1) AU702658B2 (pt)
BR (1) BR9503845A (pt)
CA (1) CA2157234C (pt)
CZ (1) CZ295675B6 (pt)
DE (1) DE69529499T2 (pt)
DK (1) DK0699677T3 (pt)
ES (1) ES2189819T3 (pt)
FI (1) FI113269B (pt)
HK (1) HK1013818A1 (pt)
HU (1) HU223776B1 (pt)
IL (1) IL115100A (pt)
IN (1) IN190402B (pt)
NO (1) NO312838B1 (pt)
PL (3) PL188796B1 (pt)
RU (1) RU2151149C1 (pt)
TR (1) TR199501071A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
NZ503301A (en) * 1997-08-12 2002-09-27 Egyt Gyogyszervegyeszeti Gyar 1,3-dioxolo[4,5-h][2,3]benzodiazepine derivatives useful as AMPA/Kainate receptor inhibitors
WO1999023242A1 (en) * 1997-11-04 1999-05-14 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
ATE425817T1 (de) * 2005-12-05 2009-04-15 Deutsche Post Ag Verfahren zum sortieren von postsendungen und vorrichtung mit einer datenstruktur fur einen sortierplan
CA2633804A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
EP0357787B1 (en) * 1988-02-12 1996-05-08 Daicel Chemical Industries, Ltd. Process for preparing optically active 2-hydroxy acid derivatives
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性（ｓ）−２−クロロ−１−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd Ｄ−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
HUT72644A (en) 1996-05-28
PL310226A1 (en) 1996-03-04
US6160133A (en) 2000-12-12
NO953396D0 (no) 1995-08-30
AU3035595A (en) 1996-03-14
JP3481019B2 (ja) 2003-12-22
CA2157234C (en) 2005-05-03
HU223776B1 (hu) 2005-01-28
US5986114A (en) 1999-11-16
PL190640B1 (pl) 2005-12-30
NO312838B1 (no) 2002-07-08
CN1123282A (zh) 1996-05-29
AU702658B2 (en) 1999-02-25
FI113269B (fi) 2004-03-31
CZ221995A3 (en) 1996-03-13
KR100399518B1 (ko) 2004-04-30
CN1086705C (zh) 2002-06-26
HU9502545D0 (en) 1995-10-30
DE69529499D1 (de) 2003-03-06
ES2189819T3 (es) 2003-07-16
ATE231867T1 (de) 2003-02-15
IL115100A (en) 2000-07-26
HK1013818A1 (en) 1999-09-10
EP0699677A1 (en) 1996-03-06
PL190318B1 (pl) 2005-11-30
CA2157234A1 (en) 1996-03-01
PL188796B1 (pl) 2005-04-29
US5919954A (en) 1999-07-06
DK0699677T3 (da) 2003-04-22
NO953396L (no) 1996-03-01
JPH0881468A (ja) 1996-03-26
IL115100A0 (en) 1995-12-08
FI954064A (fi) 1996-03-01
EP0699677B1 (en) 2003-01-29
DE69529499T2 (de) 2003-12-04
CZ295675B6 (cs) 2005-09-14
FI954064A0 (fi) 1995-08-30
TR199501071A2 (tr) 1996-06-21
KR960007595A (ko) 1996-03-22
IN190402B (pt) 2003-07-26
RU2151149C1 (ru) 2000-06-20

Similar Documents

Publication Publication Date Title
BR1100375A (pt) Composto, composição farmacêutica, e, processo para a preparação de um composto
ES2125927T3 (es) Nuevo metodo de producir 9-((glicilo substituido)amino)-6-desmetil-6-desoxitetraciclinas substituidas en la posicion 7.
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
PT80717B (pt) Processo para a preparacao de analogos de benzodiazepina
EA200000098A1 (ru) 4-АМИНОПИРРОЛ(3,2-d)ПИРИМИДИНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА НЕЙРОПЕПТИДА Y
BR9503845A (pt) Processo para a preparação de um composto e composto obtido
CA2273303A1 (en) Thienylsulfonylamino(thio)carbonyl compounds
ES2158425T3 (es) Procedimiento para la preparacion de derivados de pirimidina.
AU3210593A (en) Improvements in or relating to organic compounds
ES2120134T3 (es) Compuestos sulfonil ureas como herbicidas.
DE69724216D1 (de) Pyridin-Zwischenprodukte, verwendbar zur Herstellung von Beta-adrenergischen Rezeptor-Agonisten
PT95889A (pt) Processo para a preparacao de derivados de acido glutarico
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister
BR9610392A (pt) Processo para a preparação de derivados de rodanina substituídos com benzila

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FG9A Patent or certificate of addition granted
B24C Patent annual fee: request for for restoration

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 16A ANUIDADE.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 16A, 17A, 18A, 19A E 20A ANUIDADES. PAGAR RESTAURACAO.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.